Literature DB >> 29501072

What accounts for poor functioning in people with schizophrenia: a re-evaluation of the contributions of neurocognitive v. attitudinal and motivational factors.

Aaron T Beck1, Robyn Himelstein1, Keith Bredemeier2, Steven M Silverstein3, Paul Grant1.   

Abstract

BACKGROUND: Neurocognitive deficits are often seen as core features of schizophrenia, and as primary determinants of poor functioning. Yet, our clinical observations suggest that individuals who score within the impaired range on standardized tests can reliably perform better in complex real-world situations, especially when performance is embedded within a positive socio-affective context.
METHODS: We analyzed literature on the influence of non-neurocognitive factors on test performance in order to clarify their contributions.
RESULTS: We identified seven non-neurocognitive factors that significantly contribute to neurocognitive test performance: avolition, dysfunctional attitudes, effort, stress, negative emotions, asociality, and disorganized symptoms. We then proposed an alternative model based on dysfunctional (e.g. defeatist) attitudes and their consequences for motivation and sustained task engagement. We demonstrated that these factors account for substantial variance in negative symptoms, neurocognitive test performance, and functional outcomes. We then demonstrated that recovery-oriented cognitive therapy - which is derived from this alternative model and primarily targets dysfunctional beliefs - has been successful in the treatment of low functioning individuals with schizophrenia.
CONCLUSION: The contributions of neurocognitive impairments to poor real-world functioning in people with schizophrenia may be overstated in the literature, and may even be limited relative to non-neurocognitive factors. We offer suggestions for further research to more precisely quantify the contributions of attitudinal/motivation v. neurocognitive factors in schizophrenia.

Entities:  

Mesh:

Year:  2018        PMID: 29501072     DOI: 10.1017/S0033291718000442

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  16 in total

1.  A randomized-controlled trial of treatment for self-stigma among persons diagnosed with schizophrenia-spectrum disorders.

Authors:  Philip T Yanos; Paul H Lysaker; Steven M Silverstein; Beth Vayshenker; Lauren Gonzales; Michelle L West; David Roe
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2019-04-01       Impact factor: 4.328

2.  The meaning of group differences in cognitive test performance.

Authors:  Paul M Grant; Michael W Best; Aaron T Beck
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

3.  Physical Functional Limitations in a First-Admission Cohort at Midlife: Findings From the Suffolk County Mental Health Project.

Authors:  Sean A P Clouston; Katherine Jonas; Laura J Fochtmann; Evelyn J Bromet; Roman Kotov
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

4.  Neurocognitive deficits in schizophrenia are likely to be less severe and less related to the disorder than previously thought.

Authors:  Steffen Moritz; Stephen M Silverstein; Mona Dietrichkeit; Jürgen Gallinat
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

5.  The role of social relatedness and self-beliefs in social functioning in first-episode psychosis: Are we overestimating the contribution of illness-related factors?

Authors:  César González-Blanch; Leonardo A Medrano; Sarah Bendall; Simon D'Alfonso; Daniela Cagliarini; Carla McEnery; Shaunagh O'Sullivan; Lee Valentine; John F Gleeson; Mario Alvarez-Jimenez
Journal:  Eur Psychiatry       Date:  2020-10-09       Impact factor: 5.361

6.  Reaction Time and Visual Memory in Connection with Alcohol Use in Schizophrenia and Schizoaffective Disorder.

Authors:  Atiqul Haq Mazumder; Jennifer Barnett; Nina Lindberg; Minna Torniainen-Holm; Markku Lähteenvuo; Kaisla Lahdensuo; Martta Kerkelä; Jarmo Hietala; Erkki Tapio Isometsä; Olli Kampman; Tuula Kieseppä; Tuomas Jukuri; Katja Häkkinen; Erik Cederlöf; Willehard Haaki; Risto Kajanne; Asko Wegelius; Teemu Männynsalo; Jussi Niemi-Pynttäri; Kimmo Suokas; Jouko Lönnqvist; Solja Niemelä; Jari Tiihonen; Tiina Paunio; Aarno Palotie; Jaana Suvisaari; Juha Veijola
Journal:  Brain Sci       Date:  2021-05-23

7.  How did that interaction make you feel? The relationship between quality of everyday social experiences and emotion in people with and without schizophrenia.

Authors:  Jasmine Mote; David E Gard; Rachel Gonzalez; Daniel Fulford
Journal:  PLoS One       Date:  2019-09-30       Impact factor: 3.240

8.  New Evidences about Subjective Well-Being in Adolescence and Its Links with Neurocognitive Performance.

Authors:  Javier Ortuño-Sierra; Rebeca Aritio-Solana; Eduardo Fonseca-Pedrero
Journal:  Int J Environ Res Public Health       Date:  2020-03-13       Impact factor: 3.390

9.  Idiographic analyses of motivation and related processes in participants with schizophrenia following a therapeutic intervention for negative symptoms.

Authors:  Bénédicte Thonon; Evelyne Van Aubel; Ginette Lafit; Clara Della Libera; Frank Larøi
Journal:  BMC Psychiatry       Date:  2020-09-25       Impact factor: 3.630

10.  Executive dysfunction in schizophrenia: Predictors of the discrepancy between subjective and objective measures.

Authors:  Ingvild Haugen; Jan Stubberud; Torill Ueland; Elisabeth Haug; Merete Glenne Øie
Journal:  Schizophr Res Cogn       Date:  2021-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.